Severe infections caused by COVID-19 or influenza may raise the likelihood of developing lung cancer years later, according to new scientific findings that highlight the long-term consequences of ...

These findings, alongside the linked systematic review and meta-analysis of antiviral treatment efficacy, supported the 2024 WHO guidelines expansion of treatment criteria to include individuals with ...

Hepatitis B medication includes antiviral drugs, while the hepatitis B vaccine and shots help prevent infection and reduce serious liver complications. The post Hepatitis B Medication appeared first ...

A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists ...

In a new study, researchers found that being hospitalized for flu or COVID-19 was linked to a 24 percent increase in later ...

The introduction of highly effective direct-acting antivirals has transformed the HCV treatment landscape, enabling cure ...

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne ...

Severe COVID or flu may quietly raise lung cancer risk—but vaccines appear to stop the damage before it starts.

Virus-associated cancers are a significant and persistent global health challenge, providing unique insight into the relationship between chronic infection ...

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease’s development, but vaccination heads off those harmful effects, new research indicates.

With NIH funding, the group will pursue research and patient care approaches for a disease that affects more than 250 million people around the globe ...

Lingering inflammation from viruses like COVID-19 or HIV can take a lasting toll on the brain. New research shows exactly how specific immune system imbalances lead to memory lapses and slowed ...